Sai Phytoceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.60 Cr
as on 17-11-2024
- Paid Up Capital ₹ 5.60 Cr
as on 17-11-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.90 Cr
as on 17-11-2024
- Satisfied Charges ₹ 1.65 Cr
as on 17-11-2024
- Revenue 146.96%
(FY 2023)
- Profit 94.05%
(FY 2023)
- Ebitda 119.44%
(FY 2023)
- Net Worth 519.66%
(FY 2023)
- Total Assets 30.63%
(FY 2023)
About Sai Phytoceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.60 Cr and a paid-up capital of Rs 5.60 Cr.
The company currently has active open charges totaling ₹4.90 Cr. The company has closed loans amounting to ₹1.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Bhansali and Yash Bhansali serve as directors at the Company.
- CIN/LLPIN
U51909DL1995PTC070148
- Company No.
070148
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sai Phytoceuticals Private Limited offer?
Sai Phytoceuticals Private Limited offers a wide range of products and services, including Ayurvedic Medicine, Ayurvedic Cough & Cold Medicine, Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients).
Who are the key members and board of directors at Sai Phytoceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Bhansali  | Director | 23-Jun-1995 | Current |
| Yash Bhansali | Director | 23-Jun-1995 | Current |
Financial Performance of Sai Phytoceuticals.
Sai Phytoceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 146.96% increase. The company also saw a substantial improvement in profitability, with a 94.05% increase in profit. The company's net worth Soared by an impressive increase of 519.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Phytoceuticals?
In 2022, Sai Phytoceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jotwiring Control Systems LlpActive 6 years 11 monthsAnil Bhansali and Yash Bhansali are mutual person
- Emerald Infraispat LimitedActive 15 years 10 months
Anil Bhansali and Yash Bhansali are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Nov 2022 | ₹4.90 Cr | Open |
Others Creation Date: 20 Nov 2019 | ₹1.00 Cr | Satisfied |
Uco Bank Creation Date: 30 Dec 2006 | ₹2.15 M | Satisfied |
How Many Employees Work at Sai Phytoceuticals?
Sai Phytoceuticals has a workforce of 34 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Phytoceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Phytoceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
